Bioavailability/Bioequivalence on Biopharmaceutical Products

The Bioavailability Bioequivalence Research Center aims to become a regional center of excellence for assuring the safety and efficacy of generic pharmaceutical products for human use. It plays a key role in the drug development period for both new drug products and their generic equivalents. These studies are also important in the post approval period in the presence of certain manufacturing changes. Information in the overall set of data that ensure the availability of safe and effective medicines to patients and practitioners can be discussed

  • Factors affecting bae
  • BABE studies
  • Assesssment of bioeqivalence
  • In vivo/In vitro studies
  • Latest Updates In BA/BE

Related Conference of Bioavailability/Bioequivalence on Biopharmaceutical Products

June 06-07, 2018

International Conference on Pharmaceutical Research and Development

Philadelphia, Pennsylvania, USA
June 08-09, 2018

8th International Conference and Exhibition on GMP, GCP & Quality Control

Philadelphia, Pennsylvania, USA
June 08-09, 2018

7th International conference on Pharmaceutical Auditing

Philadelphia, Pennsylvania, USA
June 27-28, 2018

4th International Conference on Drug Discovery, Designing and Development

Vancouver, British Columbia, Canada
August 20-21, 2018

12th Asian Biologics and Biosimilars Congress

Tokyo, Japan

3rd International Conference on Generics Drugs and Biosimilars

November 15-17, 2018 | Frankfurt, Germany
October 18-19, 2018

18th World Pharma Congress

Warsaw, Poland
August 15-17, 2018

8th World Congress Spectroscopy and Analytical Techniques

Stockholm, Sweden
September 18-19, 2018

6th European Biopharma Congress

Amsterdam, Netherlands

Bioavailability/Bioequivalence on Biopharmaceutical Products Conference Speakers

Recommended Sessions

Related Journals

Are you interested in